Loading chat...
IN SB0132
Bill
Status
1/4/2017
Primary Sponsor
Jean Leising
Click for details
AI Summary
-
Grants criminal liability immunity to physicians licensed under IC 25-22.5 who obtain approval from the FDA, DEA (if required), and an institutional review board to obtain, administer, and dispense or prescribe controlled substances for medical research purposes.
-
Provides immunity for physicians' actions performed with respect to controlled substances that fall within the scope of activities authorized by the required approvals.
-
Grants criminal liability immunity to patients (ultimate users) who possess or use controlled substances prescribed or dispensed by an approved physician in accordance with the physician's instructions.
-
Excludes immunity for patients who violate the physician's instructions for possession or use of the controlled substance or any medically necessary device.
-
Effective July 1, 2017.
Legislative Description
Medical research controlled substances. Provides that a physician who has obtained approval from certain entities to obtain, administer, and dispense or prescribe a controlled substance is immune from criminal liability for the possession or distribution of the controlled substance. Provides that an ultimate user who possesses or uses a controlled substance from that prescribing or dispensing physician is immune from criminal liability for the possession or use of the controlled substance. Provides certain exceptions.
Last Action
First reading: referred to Committee on Corrections and Criminal Law
1/4/2017